2-(Pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione

Catalog No. :
ACYHER275
CAS No. :
67213-74-5
Molecular Formula :
C15H12N2O2
Molecular Weight :
252.27

IUPAC Name:2-(pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione

2-(Pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg97%$56.00Login to see priceIn stockInquiry
1g97%$155.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(Pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione
IUPAC Name2-(pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione
MDL No.MFCD03656264
Molecular FormulaC15H12N2O2
Molecular Weight252.27
SMILESO=C1N(CC2=NC=CC=C2)C(CC3=C1C=CC=C3)=O
InChI KeyNODLVRDDVBGXOY-UHFFFAOYSA-N
Synonym1,3(2H,4H)-Isoquinolinedione, 2-(2-pyridinylmethyl)-;2-(Pyridin-2-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-1,3-dione;2-(Pyridin-2-ylmethyl)isoquinoline-1,3(2H,4H)-dione
CAS No.67213-74-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACYHER275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKLWB361 route compound structure diagram
    ACKLWB36131106-82-8 In Stock
  2. Plus
  3. ACKSUG749 route compound structure diagram
    ACKSUG7494456-77-3 In Stock
  4. Then
  5. ACYHER275 route product structure diagram
    ACYHER27567213-74-5 In Stock
Inquiry

2. ACYHER275 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPSUH861 route compound structure diagram
    ACPSUH8614377-33-7 In Stock
  2. Plus
  3. ACKSUG749 route compound structure diagram
    ACKSUG7494456-77-3 In Stock
  4. Then
  5. ACYHER275 route product structure diagram
    ACYHER27567213-74-5 In Stock
Inquiry

Comments (0)